Financial News
All News about Immunocore Holdings Plc ADR
![](/next-assets/images/schema-image-default.png)
Recap: Immunocore Hldgs Q1 Earnings
May 10, 2023
Via Benzinga
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_7745.png?width=1200&height=800&fit=crop)
Analyst Ratings for Immunocore Hldgs
March 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_133.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/ep_us_feature_image_1816.jpeg?width=1200&height=800&fit=crop)
Preview: Immunocore Holdings's Earnings
February 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/22/imcr_logo_light__3251074fe1552b96bd955ca551bc0dec.png?width=1200&height=800&fit=crop)
Immunocore Reveals First Data From HIV Infection Candidate Study
February 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/nicholas-cappello-wb63zqj5gne-unsplash_11_1.jpg?width=1200&height=800&fit=crop)
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Analyst Ratings for Immunocore Hldgs
November 30, 2022
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
Immunocore to present at upcoming investor conferences
February 28, 2023
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
![](https://www.investors.com/wp-content/uploads/2023/02/sotd-for-02-13-2023-desktop-1.png)
![](https://www.marketbeat.com/logos/articles/small_stock-image_82114730_S.jpg)
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
Immunocore to present at upcoming investor conferences
February 01, 2023
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600.jpg)
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
December 16, 2022
Via Benzinga
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
Immunocore is awarded the Prix Galien France award for KIMMTRAK
December 15, 2022
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
![](https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png)
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
November 30, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.